| " IMPROVING SURVIVAL IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA IN PARAGUAY: TWINNING PROGRAM WORKS!'' A Lassaletta, D Figueredo, E Alcaraz, S Aponte, J Servin, I Mattio, ... PEDIATRIC BLOOD & CANCER 60, 66-66, 2013 | | 2013 |
| 776: MORTALITY AMONG PEDIATRIC HEMATOLOGY-ONCOLOGY PATIENTS WITH CLINICAL DETERIORATION IN LATIN AMERICA A Agulnik, MR Murguia, H Muniz-Talavera, LTD Pham, AC Aguirre, ... Critical Care Medicine 52 (1), S360, 2024 | | 2024 |
| A BCR-ABL1-like gene expression profile confers a poor prognosis in patients with high-risk acute lymphoblastic leukemia (HR-ALL): a report from Children's Oncology Group (COG … ML Loh, RC Harvey, CG Mullighan, SB Linda, M Devidas, MJ Borowitz, ... Blood 118 (21), 743, 2011 | 13 | 2011 |
| A Cloud-Based Dynamic Visualization Tool to Estimate Global Costs Associated with Childhood Cancer Medications S Hussain, Y Chen, R Ranadive, N Bolous, T Alexander, S Ozawa, ... PEDIATRIC BLOOD & CANCER 68, S109-S110, 2021 | | 2021 |
| A Comparison of Hepatotoxicity and Neutropenia in Children Given Oral Mercaptopurine on a Twice-Daily Versus Once-Daily Dosing Schedule for Acute Lymphoblastic Leukemia: A … R Chesley, BA Bell, M Devidas, B Bostrom, G Erdmann, S Sterikoff, ... Blood 104 (11), 994, 2004 | | 2004 |
| A CUSTOM QUANTITATIVE REAL TIME PCR MINIMAL RESIDUAL DISEASE (MRD) ASSAY PREDICTS OUTCOME IN MLL-REARRANGED (MLL-R) INFANT ALL: A CHILDREN'S ONCOLOGY GROUP STUDY ES Schafer, KM Murphy, K Burns, E McIntyre, MJ Borowitz, SP Hunger, ... PEDIATRIC BLOOD & CANCER 52 (6), 694-695, 2009 | | 2009 |
| A Genome-Wide Analysis of Variants Influencing Methotrexate Clearance Replicates SLCO1B1. LB Ramsey, JC Panetta, C Smith, W Yang, Y Fan, N Winick, PL Martin, ... Blood 120 (21), 2466, 2012 | | 2012 |
| A genome-wide association study identifies novel sepsis risk loci in children with Down syndrome-associated acute lymphoblastic leukemia: A report from the Children’s Oncology … MA Richard, M Devidas, W Yang, JP Woodhouse, V Rodriguez, JK Hitzler, ... Cancer Research 82 (12_Supplement), 2002-2002, 2022 | | 2022 |
| A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults V Perez-Andreu, KG Roberts, H Xu, C Smith, H Zhang, W Yang, ... Blood, The Journal of the American Society of Hematology 125 (4), 680-686, 2015 | 125 | 2015 |
| A NOVEL, CLINICALLY-RELEVANT CLASSIFICATION OF PEDIATRIC CNS TUMORS FOR CANCER REGISTRIES USING A CLUSTERING ANALYSIS D Moreira, Y Chen, I Qaddoumi, G Cioffi, K Waite, Q Ostrom, C Kruchko, ... NEURO-ONCOLOGY 24, 47-47, 2022 | 1 | 2022 |
| A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group D French, LH Hamilton, LA Mattano Jr, HN Sather, M Devidas, ... Blood, The Journal of the American Society of Hematology 111 (9), 4496-4499, 2008 | 138 | 2008 |
| A phase 2 study of ruxolitinib with chemotherapy in children with Philadelphia chromosome-like acute lymphoblastic leukemia (AALL1521/INCB18424-269): biologic characteristics … SK Tasian, DS Hunter, IML Chen, RC Harvey, AJ Carroll, E Wagner, ... Blood 140 (Supplement 1), 6117-6118, 2022 | 9 | 2022 |
| A phase 2 trial of inotuzumab ozogamicin (InO) in children and young adults with relapsed or refractory (R/R) CD22+ B-acute lymphoblastic leukemia (B-ALL): results from … MM O'Brien, L Ji, NN Shah, SR Rheingold, D Bhojwani, SY Joanna, ... Blood 134, 741, 2019 | 41 | 2019 |
| A phase 3 randomized trial of Inotuzumab Ozogamicin for newly diagnosed high-risk B-ALL: safety phase results from children's oncology group protocol AALL1732 JL McNeer, MM O'Brien, SR Rheingold, M Devidas, Z Chen, D Bhojwani, ... Blood 138, 3398, 2021 | 7 | 2021 |
| A phase 3 trial of inotuzumab ozogamicin for high-risk B-ALL: Second safety phase results from Children’s Oncology Group AALL1732. MM O'Brien, JL McNeer, SR Rheingold, M Devidas, Z Chen, D Bhojwani, ... Journal of Clinical Oncology 41 (16_suppl), 10016-10016, 2023 | 8 | 2023 |
| A pilot study of azacitidine as epigenetic priming for chemotherapy in infants less than 1 year of age with KMT2A-rearranged Acute Lymphoblastic Leukemia (ALL); Results from … E Guest, J Kairalla, M Devidas, E Hibbitts, AJ Carroll, NA Heerema, ... Blood 140 (Supplement 1), 3256-3257, 2022 | 6 | 2022 |
| A pilot study of intensified PEG-asparaginase in high-risk acute lymphoblastic leukemia: Children’s Oncology Group Study AALL08P1 V Rodriguez, J Kairalla, WL Salzer, EA Raetz, MLC Loh, AJ Carroll, ... Journal of pediatric hematology/oncology 38 (6), 409-417, 2016 | 13 | 2016 |
| A prospective study of anxiety, depression, and behavioral changes in the first year after a diagnosis of childhood acute lymphoblastic leukemia: a report from the Children's … RM Myers, L Balsamo, X Lu, M Devidas, SP Hunger, WL Carroll, ... Cancer 120 (9), 1417-1425, 2014 | 189 | 2014 |
| A randomized phase 3 trial of blinatumomab vs. chemotherapy as post-reinduction therapy in high and intermediate risk (HR/IR) first relapse of B-acute lymphoblastic leukemia (B … PA Brown, L Ji, X Xu, M Devidas, L Hogan, MJ Borowitz, EA Raetz, ... Blood 134, LBA-1, 2019 | 91 | 2019 |
| A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in Low Risk (LR) First Relapse of B-Acute Lymphoblastic Leukemia (B-ALL) in Children and … PA Brown, L Ji, X Xu, M Devidas, L Hogan, T Bhatla, M Borowitz, ... Blood 138, 363, 2021 | 14 | 2021 |